CRP and atherosclerosis: Local expression of pentraxin-3 by inflammatory and endothelial cells at the site of inflammation and atherosclerosis, in response to diverse stimuli including TNF-α as opposed to systemic production of CRP from the liver, suggests that pentraxin-3 could have a strong association with atherosclerosis [6].